CysLT1 receptor antagonist alleviates pathogenesis of collagen-induced arthritis mouse model.

Xu, Minwen; Hong, Ruiyun; Zhang, Xiaoli; Zou, Hailin; Zhang, Yi; Hou, Zhiping; Wang, Liefeng

Xu, Minwen; Hong, Ruiyun; Zhang, Xiaoli; Zou, Hailin; Zhang, Yi; Hou, Zhiping; Wang, Liefeng.

Afiliação

Xu M; First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Hong R; First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Zhang X; Department of Biotechnology, Gannan Medical University, Ganzhou, China.
Zou H; Department of Biotechnology, Gannan Medical University, Ganzhou, China.
Zhang Y; Department of Biotechnology, Gannan Medical University, Ganzhou, China.
Hou Z; Department of Biotechnology, Gannan Medical University, Ganzhou, China.
Wang L; Department of Biotechnology, Gannan Medical University, Ganzhou, China.

Oncotarget ; 8(65): 108418-108429, 2017 Dec 12.

Article em En | MEDLINE | ID: mdl-29312540

Palavras-chave

CysLT1 antagonist; IL-17A; Immune response; Immunity; Immunology and Microbiology Section; collagen-induced arthritis; cysteinyl leukotrienes; montelukast

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google